{
    "nct_id": "NCT04943848",
    "official_title": "A Phase I Clinical Trial of Neo-antigen Heat Shock Protein Vaccine (rHSC-DIPGVax) in Combination With Checkpoint Blockade for the Treatment of Diffuse Intrinsic Pontine Glioma (DIPG) and Diffuse Midline Glioma in Childhood",
    "inclusion_criteria": "* Subjects with newly diagnosed typical or non-typical, biopsy-proven DIPG or DMG are eligible for study enrollment. Biopsy is not required for subjects with radiographically typical DIPG meeting imaging criteria. Biopsy is required for DMG's and non-radiographically typical DIPG. Histone mutation must be confirmed by pathology report. Radiographically typical DIPG defined as a tumor with a pontine epicenter and diffuse involvement of more than 2/3 of the pons.\n\n  = Subjects ages > or = to 12 months and < or = 18 years (\"Lead In\", Part A, and Part B require first three patients be > or = to 12 years of age)\n* BSA > or = 0.35m2 at the time of study enrollment\n* Performance score: Karnofsky >50% of subjects >16 years of age and Lansky > or = 50 for subjects < or = 16 years of age. Subjects who are unable to walk because of paralysis but are up in a wheelchair will be considered ambulatory for the purpose of assessing the performance score.\n* Must start radiation therapy within 42 days from date of diagnostic imaging. C1D1 must be within 42 days to 70 days post radiation (6-10 weeks). Patients CANNOT receive temozolomide during radiation\n* Corticosteroids should be weaned as tolerated after radiation therapy with the goal of < or = 0.5mg/kg/day for a minimum of 7 days prior to enrollment.\n* Subjects must have measurable disease\nHealthy volunteers allowed\nMust have minimum age of 12 Months\nMust have maximum age of 18 Years",
    "exclusion_criteria": "* Patients cannot receive temozolomide during radiation\n* Disseminated disease\n* Subjects who have received any cancer therapy except for radiation\n* Autoimmune or immune disorders\n* Active respiratory disorder or infection\n* Active viral infection",
    "miscellaneous_criteria": ""
}